6FX0
Structure-based design of Trifarotene (CD5789), a potent and selective RAR gamma agonist for the treatment of acne
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID14-2 |
Synchrotron site | ESRF |
Beamline | ID14-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2003-03-06 |
Detector | ADSC QUANTUM 4r |
Wavelength(s) | 0.934 |
Spacegroup name | P 41 21 2 |
Unit cell lengths | 60.060, 60.060, 157.820 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 14.520 - 1.900 |
R-factor | 0.191 |
Rwork | 0.190 |
R-free | 0.22400 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.010 |
RMSD bond angle | 0.970 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | BUSTER (2.10.3) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.020 |
High resolution limit [Å] | 1.900 | 1.900 |
Number of reflections | 23093 | |
<I/σ(I)> | 39.59 | 15.1 |
Completeness [%] | 97.7 | 95.3 |
Redundancy | 5.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | SODIUM ACETATE, PH 7.0 |